Pelthos Therapeutics's total assets for Q3 2025 were $126.43M, an increase of 15265.25% from the previous quarter. PTHS total liabilities were $68.18M for the fiscal quarter, a 831.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.